First human test of new cancer drug halted early
NCT ID NCT06771921
Summary
This early-stage trial tested a new drug called GEN1078 in people with advanced solid cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, see how the body processes it, and get a first look at whether it might help shrink tumors. Only 3 people were enrolled before the study was terminated, so very limited information was gathered.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Integral Oncologico Clara Campal
Madrid, Spain
-
Clinica Universidad de Navarra
Pamplona, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitary Fundacion Jimenez Diaz
Madrid, Spain
-
NEXT Oncology Madrid
Madrid, Spain
-
Righshospitalet (Copenhagen University Hospital)
Copenhagen, Denmark
Conditions
Explore the condition pages connected to this study.